OLFML3 and colorectal carcinoma: Next, we evaluated OLFML3 expression in CRC patient-derived tumor xenografts (PDX) (21 primary tumors and 6 metastases of admitted tumor patients before the start of therapy, and transplanted into CB17-SCID mice (immunodeficient mice)).